Response to: “Nonalcoholic fatty liver disease in diabetes: Overlooked or just ignored?”
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related eventsJournal of Hepatology, 2022
- Poor performance of FIB-4 in elderly individuals at risk for chronic liver disease – implications for the clinical utility of the EASL NIT guidelineJournal of Hepatology, 2022
- Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver diseaseObesity, 2021
- Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver DiseaseGastroenterology, 2021
- Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic ScreeningDiabetes Care, 2021
- Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility AnalysisGastroenterology, 2020
- Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type-2 Diabetes With Biopsy-proven Nonalcoholic Fatty Liver DiseaseJournal of Clinical Gastroenterology, 2020
- Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 DiabetesDiabetes Care, 2019
- Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD FibrosisAmerican Journal of Gastroenterology, 2017
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysisPLOS Medicine, 2014